Advance could help doctors choose the right drug at the right dose for the right person UNIVERSITY OF CALIFORNIA – LOS ANGELES SMARTWATCH TO TRACK MEDICATION LEVELS view more CREDIT: JIALUN ZHU, SHUYU LIN, AND YICHAO ZHAO (I²BL/UCLA) Engineers at the UCLA Samueli School of Engineering and their colleagues at Stanford School of Medicine have...
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER COLUMBUS, Ohio – The findings of a new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) could refine an important set of prognostic and treatment recommendations for younger adult patients...
The study published in Nature identifies the mechanism used by our brain to distinguish smells. The research was conducted by IIT and Harvard University and may have an impact on the creation of the artificial sense of smell in robots ISTITUTO ITALIANO DI TECNOLOGIA – IIT Rovereto, Italy, 29th July 2020 – An Italian-American research...
WAKE FOREST BAPTIST MEDICAL CENTER In a new study from the Wake Forest Institute for Regenerative Medicine (WFIRM) researchers have developed an optimized cellular platform for delivering Factor 8 to better treat patients with hemophilia A. Hemophilia A is a genetic disorder caused by a deficiency in, or the absence of, coagulation Factor 8), an...
ALPHAMED PRESS A BIOENGINEERED SCAFFOLD CONTAINING HYPOXIA-PRECONDITIONED, ALLOGENEIC HUMAN MSCS COMBINED WITH A BETA-ADRENERGIC ANTAGONIST, TIMOLOL, TO TREAT DIABETIC WOUNDS IN MICE. THE OPTIMIZED TREATMENT IMPROVED RE-EPITHELIALIZATION BY 65.6% WITH THE… view more CREDIT: ALPHAMED PRESS Durham, NC – A new study released today in STEM CELLS Translational Medicine shows promise of a major breakthrough...
by Sara Lajeunesse, Pennsylvania State University L-type calcium channel blockers (LCCBs)—the most widely used drugs for treating hypertension—may harm the heart as much as help it, according to a new study. The research team, led by Penn State, found that in rats and human cells in vitro, LCCBs cause changes in blood vessels—known as vascular...
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER LEAD AUTHOR PHILLIP POPOVIC IS, CHAIR OF THE OHIO STATE DEPARTMENT OF NEUROSCIENCE AND EXECUTIVE DIRECTOR OF OHIO STATE’S BELFORD CENTER FOR SPINAL CORD INJURY AND CENTER FOR BRAIN… view more CREDIT: THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER COLUMBUS, Ohio – Research conducted at The Ohio State University...
MEMORIAL SLOAN KETTERING CANCER CENTER Cancer’s knack for developing resistance to chemotherapy has long been a major obstacle to achieving lasting remissions or cures. While tumors may shrink soon after chemotherapy, many times they eventually grow back. Scientists once thought that unique genetic mutations in tumors underlay this drug resistance. But more and more, they...
ALPHAMED PRESS CO-AUTHORS SO GUN HONG, DVM, PH.D., AND CYNTHIA DUNBAR, M.D., OF THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI), PART OF THE NATIONAL INSTITUTES OF HEALTH.view more CREDIT: ALPHAMED PRESS Durham, NC – A new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced from...
New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues DUKE UNIVERSITY A CLOSE-UP VIEW OF A HANDFUL OF NANOSTARS USED TO CREATE A NEW TYPE OF CANCER DIAGNOSTIC. view more CREDIT: TUAN VO-DINH, DUKE UNIVERSITY Biomedical engineers at Duke University have engineered a method for simultaneously detecting the presence of multiple...
